Insiders · KYNB

KYNB insider transactions

Kyntra Bio Inc. (KYNB) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for KYNB

• 20d
  Amendment: CEO Wettig Thane bought $19,852 worth of shares (2,800 units at $7.09), increasing direct ownership by 11% to 27,203 units (SEC Form 4)

  4/A - KYNTRA BIO, INC. (0000921299) (Issuer)
• 21d
  CEO Wettig Thane decreased direct ownership by 9% to 27,203 units (SEC Form 4)

  4 - KYNTRA BIO, INC. (0000921299) (Issuer)
• 90d
  SEC Form 4 filed by Kyntra Bio Inc.

  4 - KYNTRA BIO, INC. (0000921299) (Issuer)
• 90d
  SEC Form 4 filed by Kyntra Bio Inc.

  4 - KYNTRA BIO, INC. (0000921299) (Issuer)
• 123d
  SEC Form 4 filed by CEO Wettig Thane

  4 - KYNTRA BIO, INC. (0000921299) (Issuer)
• 123d
  SEC Form 4 filed by Chief Financial Officer Delucia David

  4 - KYNTRA BIO, INC. (0000921299) (Issuer)